Gary Gilkeson to Treatment Outcome
This is a "connection" page, showing publications Gary Gilkeson has written about Treatment Outcome.
Connection Strength
0.124
-
Differential efficacy of human mesenchymal stem cells based on source of origin. J Immunol. 2014 Nov 01; 193(9):4381-90.
Score: 0.052
-
New therapies and preventive strategies to treat and minimize damage in lupus. Curr Rheumatol Rep. 2005 Dec; 7(6):457-62.
Score: 0.028
-
Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy. Clin Rheumatol. 2014 Nov; 33(11):1611-9.
Score: 0.013
-
Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 2010 Aug; 62(8):2467-75.
Score: 0.010
-
Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis. 2010 Aug; 69(8):1423-9.
Score: 0.010
-
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med. 2005 Nov 24; 353(21):2219-28.
Score: 0.007
-
A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels. J Rheumatol. 1996 Apr; 23(4):654-8.
Score: 0.004